The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Urges Innovators to produce quality products that can be deployed at scale
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
Subscribe To Our Newsletter & Stay Updated
